Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-based drug delivery for central nervous system disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112117-112117
Open Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, et al.
IET Nanobiotechnology (2023) Vol. 17, Iss. 3, pp. 154-170
Open Access | Times Cited: 20
Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases
Phuong‐Trang Nguyen‐Thi, Thuy Trang Nguyen, Hoàng Long Phan, et al.
Neurochemistry International (2023) Vol. 170, pp. 105612-105612
Closed Access | Times Cited: 19
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartúa, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 18
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease
Punya Sachdeva, Kannan Badri Narayanan, Jitendra Kumar Sinha, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1169-1179
Closed Access | Times Cited: 8
Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, et al.
Neurochemical Research (2021) Vol. 47, Iss. 3, pp. 552-573
Closed Access | Times Cited: 40
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis
Elena Layunta, Berta Buey, José Emilio Mesonero, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 34
Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials
Brandon Conklin, Brian Conley, Yannan Hou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114636-114636
Open Access | Times Cited: 27
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects
Saad Alkahtani, Norah S. AL–Johani, Saud Alarifi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1340-1340
Open Access | Times Cited: 15
A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 507-526
Closed Access | Times Cited: 5
Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment
Suganiya Umapathy, Ieshita Pan, Praveen Kumar Issac, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone
Diana Díaz‐García, Águeda Ferrer-Donato, José M. Méndez‐Arriaga, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 11, pp. 4838-4849
Open Access | Times Cited: 22
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Christoph Hieber, Stephan Grabbe, Matthias Bros
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 12
Magnetic hybrid nanovesicles for the precise diagnosis and treatment of central nervous system disorders
Sara Salatin, Mehdi Farhoudi, Saeed Sadigh‐Eteghad, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 521-535
Closed Access | Times Cited: 4
Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery
Ly Porosk, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 83-104
Closed Access
Nanoparticle-Mediated Gene Therapy for Neurological Disorders
Chetna Modi, Meena Arora, Bhavisha Dudhatra, et al.
Nanotechnology in the life sciences (2025), pp. 25-42
Closed Access
Imaging Probes for the Detection of Brain Microenvironment
Shiming Zhang, Tianyu Wang, Tianzi Gao, et al.
Colloids and Surfaces B Biointerfaces (2025), pp. 114677-114677
Closed Access
Core-/Multi-Shell Type of Core-Shell Nanoconstruct for Cancer Theragnostics
Bharat Mishra, Archita Tiwari, Shrishti Mishra, et al.
(2025), pp. 107-136
Closed Access
Lyotropic liquid crystalline nanoparticles of morin: An approach to improve pharmacokinetics and brain disposition in rats via nose-to-brain pathway
Dhrumi Patel, Sarika Wairkar
Nanomedicine Nanotechnology Biology and Medicine (2025), pp. 102823-102823
Closed Access
Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms
Jianping Han, Xue Zhang, Lixing Kang, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections
Dounia Elfadil, Walid F. Elkhatib, Gharieb S. El‐Sayyad
Microbial Pathogenesis (2022) Vol. 170, pp. 105721-105721
Closed Access | Times Cited: 17
Cell membrane-based nanomaterials for theranostics of central nervous system diseases
Wenyue Li, Junwei Cheng, Fangfei He, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Advances in the study of polydopamine nanotechnology in central nervous system disorders
Sijing Ren, Xiangyu Xiao, Jiahua Lv, et al.
Frontiers in Materials (2024) Vol. 11
Open Access | Times Cited: 3
Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
Tanvir Ahmed
European Journal of Neuroscience (2024) Vol. 59, Iss. 11, pp. 2915-2954
Closed Access | Times Cited: 3
Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review
Antea Kršek, Ana Jagodic, Lara Batičić
Medicina (2024) Vol. 60, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 3
Neurotoxicity mechanisms and clinical implications of six common recreational drugs
Jing Wang, Yulei Hao, Ma Di, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Scroll to top